SAN DIEGO--(BUSINESS WIRE)--TrovaGene, Inc., a developer of transrenal molecular diagnostics, announced today that Dr. Andreas Braun has joined the company as its Vice President and Chief Medical Officer. Dr. Braun has over 25 years of direct industry experience in developing molecular diagnostic assays for the clinical reference laboratory.
